rs115270700 - C1QTNF12 - UBE2J2
Magnitude 4.5 · 1 study on file
Reported associations
-
Impact of Evolutionary Changes in Nonalcoholic Fatty Liver Disease on Lung Function Decline - Unknown journal (n.d.) · Unknown authors · PubMed 35611668
ABSTRACT: Background/Aims A relationship between fatty liver and lung function impairment has been identified, and both are independently associated with metabolic dysfunction. However, the temporal relationship between changes in fatty liver status and lung function and their genome-wide association remain unclear. Methods This longitudinal cohort consisted of subjects who received serial health check-ups, including liver ultrasonography and spirometry, for ≥3 years between 2003 and 2015. Lung function decline rates were classified as "slow" and "accelerated" and compared among four different sonographic changes in steatosis status "normal," "improved," "worsened," and "persistent." A genome-wide association study was conducted between the two groups normal/impro
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Bloodwork
-
metabolic panel: fasting glucose, lipids, liver enzymes Moderate
Insulin resistance and systemic inflammation mediate rs115270700 association with accelerated lung decline; monitoring guides intervention efficacy
annually
Diet
-
weight management via caloric restriction Moderate
Study shows rs115270700 C allele amplifies lung decline risk in metabolic dysfunction context; weight loss prevents fatty liver progression
target 5-10% weight reduction if BMI >25
Discuss with your doctor
-
metabolic syndrome and fatty liver risk assessment Moderate
rs115270700 shows pleiotropic effect linking metabolic dysfunction to both fatty liver and lung decline; clinical assessment identifies modifiable pathways
Lifestyle
-
regular physical activity Moderate
rs115270700 C allele associated with accelerated FEV1 decline; physical activity improves insulin sensitivity and reduces systemic inflammation
150 minutes moderate intensity weekly
Screening
-
spirometry for lung function decline Moderate
rs115270700 C allele shows genome-wide significant association with accelerated FEV1 decline; baseline and serial screening enables early detection
baseline spirometry, repeat annually or every 2 years